Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Clearside Biomedical, Inc.
A randomized, masked, controlled trial of safety and efficacy of suprachoroidal CLS-TA in combination with intravitreal aflibercept in subjects with macular edema following retinal vein occlusion
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
diagnosis of macular edema following RVO
History of ME ≤ 12 months
20-70 letters inclusive BCVA using ETDRS
You may not be if
has had an IVT injection of anti-VEGF for RVO in the study eye
has had a corticosteroid injection in the past 3 months in the study eye
any uncontrolled ophthalmic condition in the study eye other than RVO
